Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen?
1991

Study of Small Intestine Cancer and Bile's Role

Sample size: 1190 publication Evidence: moderate

Author Information

Author(s): R.K. Ross, N.M. Hartnett, L. Bernstein, B.E. Henderson

Primary Institution: Kenneth Norris Jr. Comprehensive Cancer Center, USC School of Medicine

Hypothesis

Is bile a small bowel carcinogen?

Conclusion

The study suggests that bile and pancreatic secretions may contribute to the development of adenocarcinomas in the small intestine.

Supporting Evidence

  • Fifty percent of all small intestinal adenocarcinomas occurred in the duodenum.
  • The duodenum accounts for about 4% of the entire length of the small bowel but has a high incidence of adenocarcinomas.
  • The majority of adenocarcinomas in the duodenum were located near the Ampulla of Vater.

Takeaway

This study looked at cancer cases in the small intestine and found that many adenocarcinomas happen in a small part called the duodenum, which is near where bile enters the intestine.

Methodology

The study analyzed pathology reports and data from a cancer registry covering the period from 1972 to 1985.

Limitations

The rarity of small bowel cancers limits the ability to conduct detailed studies on their causes.

Participant Demographics

The study included a diverse population from Los Angeles County, with a focus on racial and ethnic differences in cancer incidence.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication